1[1]Ben-David Y,Rosen B,Franssen E,et al. Meta-analysis comparing cisplatin total dose intensity and survival. Gynecol Oncol, 1995,59..93.
2[2]Ozols RF,Behrens BC,Ostchega,et al. High dose cisplatin and high dose carbopltin in refractory ovarian cancer. Cancer Treat Rev,1985,12:58.
3[3]Kirmani S,Braly PS,McClay EF,et al. A comparison of intravenous versus intraperitoneal for the initial treatment of ovarian cancer. Gynecol Oncol, 1994,54: 338.
4[4]Plaxe,S,Fraddo J,Kim S,et al. Phase I trial of cisplatin in combination with glutathione. Gynecol Oncol, 1994,55: 82.
